Drug-related administration to be deregulated

The pharmaceutical industry is expected to enjoy deregulation as the Korea Food and Drug Administration has adopted a series of measures to overhaul drug-related administration since May 1.

·Approval of bioequivalence testing will be made available through the review of documents concerning safety and efficacy of drugs;

·In-house standards drug based on standard manufacture criteria will ...